As a provider and leader in ultrasound-guided interventional solutions, Jingfang Medical made a significant appearance at this conference. Adhering to its core values ​​of "pioneering innovation, pursuing excellence, striving for perfection, and fulfilling customer needs," the company is committed to providing customers with safe, reliable, and cost-effective interventional medical products.

Jingfang Medical's integrated urological biopsy solution, showcased at this year's annual meeting, attracted considerable attention. From transrectal and transperineal prostate biopsies to grid template prostate biopsies, the comprehensive solutions fully demonstrated Jingfang Medical's profound technical expertise and professional strength.

Transrectal Biopsy Protocol

• Fully automated biopsy needle: Enhanced tip imaging, full sample collection, and flexible operation.
• Disposable endocavity needle guides: Pure metal needle path, visualized needle insertion, precise guidance.

Transperineal Biopsy Protocol

• Fully automated biopsy needle: Enhanced tip imaging, full sample collection, and flexible operation.
• Disposable transperineal needle guides: Sliding track, positioning block optional, multi-plane guidance.

Grid Template Biopsy Protocol

• Fully automated biopsy needle: Enhanced tip imaging, full sample collection, and flexible operation.
• Disposable template grids: Funnel-shaped needle inlet, expandable channel at the bottom.

The EAU26 conference highlighted significant breakthroughs in prostate cancer screening, with screening methods evolving from opportunistic testing to standardized, risk-stratified systems. The PRAI (Prostate Risk Assessment & Intervention) consensus further emphasizes the necessity of precision-guided biopsies in future clinical workflows.

Copyright © 2009-2026 InnoFine Medical Limited. All Rights Reserved.